The dietary supplement market often markets L-arginine as the gold standard for nitric oxide synthesis, yet pharmacokinetics demonstrate a significant hepatic first-pass extraction that drastically reduces systemic availability. When consumed orally, up to seventy percent of free-form L-arginine is metabolized before reaching vascular endothelial tissue. Our evaluation index tracks whether a circulation formula respects this metabolic reality or leans on obsolete compounding habits.
The Pharmacokinetic Advantage of L-Citrulline
L-citrulline bypasses first-pass hepatic metabolism entirely, converting to L-arginine within the kidneys to generate sustained plasma concentrations. A literature check demonstrates that 3,000 to 6,000 milligrams of pure L-citrulline reliably elevates serum arginine levels far more effectively than equivalent direct arginine dosing. Formulas that include less than 2,000 milligrams fail our threshold for clinically relevant vascular health support.
Auditing Citrulline Malate Ratios
When brands switch to citrulline malate, transparency frequently collapses. A true 2:1 bonded citrulline malate provides roughly sixty-six percent active citrulline by weight, meaning an eight-gram dose yields slightly over five grams of the active compound. Many manufacturers substitute unbonded physical mixtures or fail to state the ratio entirely, masking inadequate active yields behind inflated gross weight claims.
Scoring Methodology for Endothelial Support
We penalize products that fail to specify whether their citrulline compound is fermented, synthetic, or blended with unbonded malic acid filler. Consumers assessing a product for blood flow, recovery, or blood pressure maintenance should look for explicit third-party verified lot testing confirming purity and verified active mass before purchasing.